Publications in collaboration with researchers from Harvard Medical School (15)

2024

  1. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial

    Archivos de Bronconeumologia, Vol. 60, Núm. 7, pp. 417-422

2023

  1. Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program

    Annals of Epidemiology, Vol. 77, pp. 1-12

2022

  1. COPD detection in lung cancer screening programmes: “hitting two birds with one stone”

    European Respiratory Journal

  2. Chest CT-assessed comorbidities and all-cause mortality risk in COPD patients in the BODE cohort

    Respirology, Vol. 27, Núm. 4, pp. 286-293

  3. Comorbidities and mortality risk in adults younger than 50 years of age with chronic obstructive pulmonary disease

    Respiratory Research, Vol. 23, Núm. 1

  4. Inhaled corticosteroids, COPD, and the incidence of lung cancer: a systematic review and dose response meta-analysis

    BMC Pulmonary Medicine, Vol. 22, Núm. 1

  5. Severe exacerbations and mortality in COPD: Importance of both body and mind

    Respirology

2021

  1. Nocturnal hypoxemia and CT determined pulmonary artery enlargement in smokers

    Journal of Clinical Medicine, Vol. 10, Núm. 3, pp. 1-12

  2. Psoas Muscle Density Evaluated by Chest CT and Long-Term Mortality in COPD Patients

    Archivos de Bronconeumologia, Vol. 57, Núm. 8, pp. 533-539

2020

  1. A delphi consensus document on the use of single-inhaler fixed-dose triple therapies in copd patients

    International Journal of COPD, Vol. 15, pp. 1801-1811

  2. Somatotypes trajectories during adulthood and their association with copd phenotypes

    ERJ Open Research, Vol. 6, Núm. 3, pp. 1-9

2019

  1. B cell-adaptive immune profile in emphysema-predominant chronic obstructive pulmonary disease

    American Journal of Respiratory and Critical Care Medicine

2015

  1. Lung cancer in patients with chronic obstructive pulmonary disease: Development and validation of the COPD lung cancer screening score

    American Journal of Respiratory and Critical Care Medicine, Vol. 191, Núm. 3, pp. 285-291

2002

  1. Molecular profiling of angiogenesis markers

    American Journal of Pathology, Vol. 161, Núm. 1, pp. 35-41

  2. Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD

    Chest, Vol. 121, Núm. 4, pp. 1092-1098